3,149
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Who is more likely to hesitate to accept COVID-19 vaccine: a cross-sectional survey in China

, , , , , , , , , , & show all
Pages 397-406 | Received 20 Mar 2021, Accepted 14 Dec 2021, Published online: 06 Jan 2022

References

  • World Health Organization(WHO). Geneva: WHO. [ cited 2021 Feb 11]. Available from: http://www.who.int/dg/briefingoncovid-19-11-march-2020
  • Eubank S, Eckstrand I, Lewis B, et al. Commentary on Ferguson, et al., Impact of non-pharmaceutical Interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. Bull Math Biol. 2020;82:52.
  • World Health Organization(WHO). Geneva: WHO. [ cited 2021 Feb 21]. Available from: https://covid-19.who.int
  • Gao Q, Bao L, Mao H, et al. Development of an inactivated vaccine candidate for SARS-CoV-2. Science. 2020;369:77–81.
  • Yamey G, Schäferhoff M, Hatchett R, et al. Ensuring global access to COVID-19 vaccines. Lancet. 2020;395:1405–1406.
  • Mcclure CC, Cataldi JR, O’Leary ST. Vaccine hesitancy: where we are and where we are going. Clin Ther 2017;39:1550–1562.
  • Dubé E, Vivion M, Macdonald NE, Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: influence, impact and implications. Expert Rev Vaccines. 2015;14:99–117.
  • Sallam M, Dababseh D, Eid H, et al. High rates of COVID-19 vaccine hesitancy and its association with conspiracy beliefs: a study in Jordan and Kuwait among Other Arab Countries. Vaccines (Basel). 2021;9:42.
  • Murphy J, Vallières F, Bentall RP, et al. Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom. Nat Commun 2021;12:29.
  • Lane S, Macdonald NE, Marti M, et al. Vaccine hesitancy around the globe: analysis of three years of WHO/UNICEF joint reporting form data-2015-2017. Vaccine. 2018;36:3861–3867.
  • World Health Organization(WHO). Geneva: WHO. [ cited 2020 Dec 21]. Available from:https://www.who.int/emergencies/ten-threats-to-global-health-in-2019
  • Cella P, Voglino G, Barberis I, et al. Resources for assessing parents‘ vaccine hesitancy: a systematic review of the literature. J Prev Med Hyg. 2020;61(3):E340–E373.
  • Dubé E, Gagnon D, Macdonald N, et al. Underlying factors impacting vaccine hesitancy in high income countries: a review of qualitative studies. Expert Rev Vaccines. 2018;17:989–1004.
  • Dubé E, Laberge C, Guay M, et al. Vaccine hesitancy: an overview. Hum Vaccin Immunother. 2013;9:1763–1773.
  • COCONEL Group. A future vaccination campaign against COVID-19 at risk of vaccine hesitancy367 and politicization. Lancet Infect Dis. 2020;5:769–770.
  • Africa CDC. Addis Ababa: Africa CDC. [ cited 2021 Jan 2]. Available from: https://africacdc.org/news-item/majority-of-africans-would-take-a-safe-and-effective-covid-19-vaccine
  • Edwards B, Biddle N, Gray M, et al. COVID-19 vaccine hesitancy and resistance: correlates in a nationally representative longitudinal survey of the Australian population. PLoS One. 2021;16:e0248892.
  • Yoda T, Katsuyama H. Willingness to receive COVID-19 vaccination in Japan. Vaccines (Basel). 2021;9:48.
  • Sherman SM, Smith LE, Sim J, et al. COVID-19vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey. Hum Vaccin Immunother. 2020;11. 1–10.
  • Sadaf A, Richards JL, Glanz J, et al. A systematic review of interventions for reducing parental vaccine refusal and vaccine hesitancy. Vaccine. 2013;31:4293–4304.
  • Neumann-Böhme S, Varghese NE, Sabat I, et al. Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. Eur J Health Econ. 2020;21:977–982.
  • Dror AA, Eisenbach N, Taiber S, et al. Vaccine hesitancy: the next challenge in the fight against COVID-19. Eur J Epidemiol. 2020;35:775–779.
  • Barello S, Nania T, Dellafiore F, et al. ‘Vaccine hesitancy’ among university students in Italy during the COVID-19 pandemic. Eur J Epidemiol. 2020;35:781–783.
  • Harrison EA, Wu JW. Vaccine confidence in the time of COVID-19. Eur J Epidemiol. 2020;35:325–330.
  • Puri N, Coomes EA, Haghbayan H, et al. Social media and vaccine hesitancy: new updates for the era of COVID-19 and globalized infectious diseases. Hum Vaccin Immunother. 2020;16:2586–2593.
  • Halvorsen K, Dihle A, Hansen C, et al. Empowerment in healthcare: a thematic synthesis and critical discussion of concept analyses of empowerment. Patient Educ Couns. 2020;103:1263–1271.
  • Launiala A. How much can a KAP survey tell us about people’s knowledge, attitudes and practices? Some observations from medical anthropology research on malaria in pregnancy in Malawi. Anthropol Matters. 2009;11:1–13.
  • Ning LW, Niu J, Bi X, et al. The impacts of knowledge, risk perception, emotion and information on citizens’ protective behaviors during the outbreak of COVID-19: a cross-sectional study in China. BMC Public Health. 2020;20:1751.
  • Lindell MRW. Behavioral foundation of community emergency planning. Florida State: Hemisphere Publishing Corp; 1992.
  • Moran MB, Frank LB, Chatterjee JS, et al. Information scanning and vaccine safety concerns among African American, Mexican American, and non-Hispanic white women. Patient Educ Couns. 2016;99:147–153.
  • Casciotti DM, Smith KC, Tsui A, et al. Discussions of adolescent sexuality in news media coverage of the HPV vaccine. J Adolesc. 2014;37:133–143.
  • Catalan-Matamoros D. The great development of the scientific and academic field of health communication. Rev Esp Comun Salud. 2017;8:114–117.
  • Kim CW, Song HR. Structural relationships among public’s risk characteristics, trust, risk perception and preventive behavioral intention: the case of MERS in Korea. Crisis Emergency Manage. 2017;13:85–95.
  • Finucane ML, Alhakami A, Slovic P, et al. The affect heuristic in judgments of risks and benefits. J Behav Decis Making. 2000;13:1–17.
  • Caserotti M, Girardi P, Rubaltelli E, et al. Associations of COVID-19 risk perception with vaccine hesitancy over time for Italian residents. Soc Sci Med. 2021;272:113688.
  • Kasperson Regd TS. Social distrust as a factor in sitting hazardous facilities and communicating risks. J Soc Issues. 1992;8:161–187.
  • China CDC. Bejing: China CDC. [ cited 2020 Dec 23]. Available from: http://www.chinacdc.cn
  • National Health Commission of People’s Republic of China. Commission of People’s Republic of China. Beijing: National Health. [ cited 2020 Dec 23]. Available from: http://www.nhc.gov.cn/wjw/zhuant/ztzl.shtml
  • Gualano MR, Corradi A, Voglino G, et al. Healthcare workers’ (HCWs) attitudes towards mandatory influenza vaccination: a systematic review and meta-analysis. Vaccine. 2021;39:901–914.
  • MacDonald NE. SAGE working group on vaccine hesitancy. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33:4161–4164.
  • Salali GD, Uysal MS. COVID-19 vaccine hesitancy is associated with beliefs on the origin of the novel coronavirus in the UK and Turkey. Psychol Med. 2020;9:1–3.
  • Sallam M. COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines (Basel). 2021;9:160.
  • Ridgeway CL. Small-group interaction and gender. Int Encycloped Soc Behav Sci. 2001;1:14185–14189.
  • Kailu W, Wong ELY, Ho KF, et al. Intention of nurses to accept coronavirus disease 2019 vaccination and change of intention to accept seasonal influenza vaccination during the coronavirus disease 2019 pandemic: a cross-sectional survey. Vaccine. 2020;38:7049–7056.
  • Di Giuseppe G, Pelullo CP, Della Polla G, et al. Exploring the willingness to accept SARS-CoV-2 vaccine in a university population in Southern Italy, September to November 2020. Vaccines (Basel). 2021;9:275.
  • Frank K, Arim R. Canadians’ willingness to get aCOVID-19 vaccine: group differences and reasons for vaccine hesitancy; [ cited 2020 Dec 23]. Available from: https://www.researchgate.net/publication/343858179
  • Zhaobin L, Guizhi W. Adverse reaction causes and the countermeasures in preventive vaccination. Med Diet Ther Health 2020;20:12–13.
  • Luci VC, Kelekar A, Afonso NM. COVID-19 vaccine hesitancy among medical students. J Public Health. 2021;2:1–5.
  • Omoleke S, Ajibola O, Omisakin O, et al. Vaccine hesitancy among medical practitioners. Sahel Med J. 2020;23:126.
  • Wang X, Zhou X, Leesa L, et al. The effect of vaccine literacy on parental trust and intention to vaccinate after a major vaccine scandal. J Health Commun. 2018;23:413–421.
  • Wilson L, Rubens-Augustson T, Murphy M, et al. Barriers to immunization among newcomers: a systematic review. Vaccine. 2018;36:1055–1062.
  • Betsch C, Renkewitz F, Betsch T, et al. The influence of vaccine-critical websites on perceiving vaccination risks. J Health Psychol. 2010;15:446–455.
  • Neufeind J, Betsch C, Zylka-Menhorn V, et al. Determinants of physician attitudes towards the new selective measles vaccine mandate in Germany. BMC Public Health. 2021;21:566.
  • Papagiannis D, Rachiotis G, Malli F, et al. Acceptability of COVID-19 vaccination among Greek health professionals. Vaccines (Basel). 2021;9:200.
  • ECDC [Technical report], vaccine hesitancy among healthcare workers and their patients in Europe. Solna: ECDC. [ cited 2021 Jan 20]. Available from: https://www.ecdc.europa.eu/sites/default/fifiles/media/en/publications/Publications/vaccine-hesitancy-amonghealthcare-workers.pdf
  • Andrew MK, Gilca V, Waite N, et al. Examining the knowledge, attitudes and experiences of Canadian seniors towards influenza (the EXACT survey). BMC Geriatr. 2019;19:178.
  • Usami T, Hashiguchi M, Kouhara T, et al. Impact of community pharmacists advocating immunization on influenza vaccination rates among the elderly. Yakugaku Zasshi. 2009;129:1063–1068.
  • Xiaofei X, Rui Z, Dongmei X, et al. Psychological panic phenomenon in SARS. Beijing Univ Nat Sci. 2005;41:628–638.
  • Yajun D, Yanhua H, Qunhong W, et al. Establishment and evaluation on reliability and validity of public risk perception scale for public health emergencies. Chin J Public Health. 2020;36:227–231.
  • Bacon SL, Lavoie KL, Boyle J, et al. International assessment of the link between COVID-19 related attitudes, concerns and behaviours in relation to public health policies: optimizing policy strategies to improve health, economic and quality of life outcomes (theiCARE Study). BMJ Open. 2021;11:e046127.
  • Weinstein ND, Kwitel A, McCaul KD, et al. Risk Perceptions: assessment and relationship to influenza vaccination. Health Psychol. 2007;26:146–151.
  • Cho J, Lee JLJ. An integrated model of risk and risk-reducing strategies. J Bus Res 2006;59:112–120.
  • Leask J, Willaby HW, Kaufman J. The big picture in addressing vaccine hesitancy. Hum Vaccin Immunother. 2014;10:2600–2602.
  • Zheng W. Progress on vaccine hesitancy and its influential factors. Prog Microbiol Immunol. 2019;47:74–78.
  • World Health Organization. Geneva: WHO. [ cited 2021 Jan 20]. Available from: https://www.who.int/zh/news-room/detail/18-08-2015-vaccine-hesitancy-a-growing-challenge-for-immunization-programmes
  • Ullah I, Khan KS, Tahir MJ, et al. Myths and conspiracy theories on vaccines and COVID-19: potential effect on global vaccine refusals. Vacunas. 2021;22:93–97.
  • Sherman SM, Smith LE, Sim J, et al. COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey. Hum Vaccin Immunother. 2021;17:1612–1621.
  • Yurttas B, Poyraz BC, Sut N, et al. Willingness to get theCOVID-19 vaccine among patients with rheumatic diseases, healthcare workers and general population in Turkey: a web based survey. Rheumatol Int. 2021;41:1105–1114.
  • Rodriguez SA, Mullen PD, Lopez DM, et al. Factors associated with adolescent HPV vaccination in the U.S.: a systematic review of reviews and multilevel framework to inform intervention development. Prev Med. 2020;131:105968.
  • Gualano MR, Olivero E, Voglino G, et al. Knowledge, attitudes and beliefs towards compulsory vaccination: a systematic review. Hum Vaccin Immunother. 2019;15:918–931.
  • Batniji R. Historical evidence to inform COVID-19 vaccine mandates. Lancet. 2021;397:791.
  • Hill A, Khoo S, Fortunak J, et al. Minimum costs for producing hepatitis C direct-acting antivirals for use in large-scale treatment access programs in developing countries. Clin Infect Dis. 2014;58:928–936.
  • Binagwaho A, Mathewos K, Davis S. Equitable and effective distribution of the covid-19 vaccines-a scientific and moral obligation. Int J Health Policy Manag. 1 Jun 2021;3. DOI:https://doi.org/10.34172/ijhpm.2021.49.
  • National Health Commission of People’s Republic of China. Commission of People’s Republic of China. Beijing National Health. [ cited 2021 Jan 26; cited 26 Dec 2020]. Available from http://en.nhc.gov.cn/2021-01/05/c_82655.htm
  • World Health Organization(WHO). Geneva: WHO. [ cited 2021 Jun 1]. Available from: https://www.who.int/news-room/events/detail/2021/05/21/default-calendar/global-health-summit-2021
  • Colombo SA. BBC. [ cited 2021 Jan 22]. Available from:https://www.bbc.com/news/world-africa-55751714
  • UNICEF. Kathmandu: UNICEF. [ cited 2021 Apr 26]. Available from:https://www.unicef.org/rosa/press-releases/unicef-launches-covid-19-vaccine-market-dashboard